版本:
中国

BRIEF-Titan Pharmaceuticals posts Q4 loss per share $0.11

March 16 Titan Pharmaceuticals Inc

* Titan pharmaceuticals reports full year and fourth quarter 2016 financial results

* Q4 loss per share $0.11

* At dec. 31, 2016, co had cash of approximately $14.0 million, compared with approximately $7.9 million at dec. 31, 2015

* Its working capital at Dec. 31, 2016 is sufficient to fund operations through Q1 of 2018 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐